THE GENERAL HOSPITAL CORPORATION;DANA-FARBER CANCER INSTITUTE INC.
发明人:
Nir Hacohen,Catherine Ju-Ying Wu
申请号：
US15800732
公开号：
US20180055922A1
申请日:
2017.11.01
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention related to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. Specifically, the invention provides a method of identifying tumor specific neoantigens that alone or in combination with other tumor-associated peptides serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor responses.
